MUMBAI, India, Oct. 11 -- Intellectual Property India has published a patent application (202517066944 A) filed by Urteste S. A., Gdansk, Poland, on July 14, for 'compound - diagnostic marker for biliary tract cancer, method for detecting enzymatic activity, method for diagnosis of biliary tract cancer, kit comprising the compound, uses of the compound and method for the treatment of biliary tract cancer.'
Inventor(s) include Lesner, Adam; and Gruba, Natalia.
The application for the patent was published on Oct. 10, under issue no. 41/2025.
According to the abstract released by the Intellectual Property India: "The invention relates to a novel chemical compound - a diagnostic marker for use in medicine, more specifically in cancer diagnosis, in particular the diagnosis of biliary tract cancer. The invention also relates to an in vitro method for detecting enzymatic activity present in a subject's body fluid, in particular derived from biliary tract cancer cells, using the compound. The invention further relates to an in vitro method for diagnosing biliary tract cancer using the compound, a kit comprising the compound and use of the compound for the detection of enzymatic activity specific to biliary tract cancer and use of the compound for the diagnosis of biliary tract cancer. The invention also relates to the compound for use as a diagnostic marker of biliary tract cancer and a method for the treatment of biliary tract cancer comprising a step of carrying out the method for the diagnosis of biliary tract cancer as defined above using the compound."
The patent application was internationally filed on Jan. 08, 2024, under International application No.PCT/PL2024/050001.
Disclaimer: Curated by HT Syndication.
